Sign in Create free account

1material signals today 174IPOs 65buybacks 19OFSNSE · IST

Signals

00:07ADANIENSOLInvestors' Presentation On Unaudited Financial Results (Standalone And Consolidated) For The Quarter and half…Major
23:07SWELECTESAcquisition of 100% (one hundred percent) equity shares of SUSHMA SOLAR ENERGY PRIVATE LIMITED, a Company…Major
21:12CYBERTECHFinancial results for the period ended September 30, 2026
20:49HFCLIncorporation of HFCL Connectivity Systems Limited, as a Wholly-Owned Subsidiary Company of HFCL Limited (…
20:18INDOBORAXAmendment of the Share Purchase AgreementMajor
20:07NLCINDIAPress release dated October 22, 2026, titled "NLCIL Signs MoU with IPICOL for Establishment of a 3200 MW…
19:50SURYODAYBoard meeting of the Bank on October 22, 2026, for considering raising of funds by issue of Non
19:13MARATHONPress release dated October 22, 2026, titled "Financial results for the second quarter and half year ended…Major
19:12SAMMAANCAPFund raising approved
19:09PITTIENGApproval of Capex and capacity expansion
19:04SAMMAANCAP(CIN: L65922DL2005PLC136029)
19:00BLUESTONEFund Raising in accordance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015…
18:58NUVOCOPress release dated October 22, 2026, titled "Nuvoco Vistas announces its financial results for Q2 FY27"Major
18:48SAGILITYBoard of Directors at its meeting held on October 22, 2026, declared Interim Dividend of Rs. 0.15 per equity…
18:46ORIENTCEMFinancial results for the period ended September 30, 2026
18:39MAITHANALLAcquisition of Equity Shares through Stock Exchange
18:39BLUESTONEFinancial results for the quarter ended September 30, 2026Major
18:37SAGILITYFinancial results for the period ended September 30, 2026
18:35SWASTIKAINReport of the Monitoring Agency with respect to utilization of proceeds of the Initial Public Offering (IPO)…Special Situation
18:32PITTIENGFinancial results for the period ended September 30, 2026Major

Sahajanand Medical Technologies Limited

allotmentRefreshing

NSE · Source: INVESTORGAIN

DRHP11 Oct 2026completed
RHP10 Oct 2026completed
Price band10 Oct 2026completed
Opened15 Oct 2026completed
Closed19 Oct 2026completed
Allotted21 Oct 2026completed
Listing23 Oct 2026current stage

Price band

₹327–₹344

Issue size

₹475.48 Cr

Fresh issue

—

Offer for sale

—

GMP ₹16 (4.65%)grey-market · 8 hr ago

Bull / base / bear

What would have to hold for each case — not a price target or a projected figure. CapitSignal does not forecast where this stock trades.

Bull case

The company successfully expands its market share in the vascular intervention segment.
The company has a market share of nearly 25.00% in the drug-eluting stents market in India, indicating strong competitive positioning.
Regulatory approvals for new products are obtained without delays.
The company has a history of receiving necessary approvals for its innovative products, such as the Supraflex Cruz.
The global cardiovascular devices market continues to grow as projected.
The global cardiovascular devices market is expected to reach USD 37.8 billion by 2030, driven by increasing disease prevalence.
The company maintains strong relationships with its top distributors.
Top 10 distributors contributed 18.60% to revenue from operations in the three months ended June 30, 2026, highlighting their importance.

Base case

The company continues its current growth trajectory in revenue.
The company reported total revenue from operations of ₹3,516.69 million for the three months ended June 30, 2026, consistent with prior fiscal growth.
The Supraflex Cruz remains a leading product in its category.
The Supraflex Cruz contributed 39.00% to total revenue from operations in the three months ended June 30, 2026.
The company effectively manages its supply chain and raw material costs.
Total purchases from top 10 suppliers accounted for 63.61% of total purchases, indicating a reliance that must be managed.